Facilitating Collaborations to Develop Combination Investigational Cancer Therapies
Subtitle: workshop summary
By: Margie Patlak, Erin Balogh, and Sharyl J. Nass, rapporteurs ; National Cancer Forum ; Board on Health care Services, Institute of Medicine of the National Academies
Contributors: Patlak, Margie; Balogh, Erin; Nass, Sharyl J.; Institute of Medicine (U.S.). Board on Health Care Services; National Cancer Policy Forum (U.S.)
Publisher: National Academies Press
Published: 2012
Place of publication: Washington, D. C
Language: eng
Number of pages: 103
Subjects: Cancer; Congresses; Research; Combination Chemotherapy; Academic-industrial collaboration; Neoplasms; Drug therapy; Combination Drug Therapy; Cooperative Behavior
Description: Advances in biomedical research have increased our understanding of the complex nature of disease and the interaction of multiple molecular pathways involved in cancer. Combining investigational products early in their development is thought to be a promising strategy for identifying effective therapies. The IOM's National Cancer Policy Forum held a workshop to discuss challenges and identify potential solutions to improve collaboration and advance the development of combination investigational cancer therapies.

"Advances in biomedical research have increased our understanding of the complex nature of disease and the interaction of multiple molecular pathways involved in cancer. Combining investigational products early in their development is thought to be a promising strategy for identifying effective therapies. The IOM's National Cancer Policy Forum held a workshop to discuss challenges and identify potential solutions to improve collaboration and advance the development of combination investigational cancer therapies."--from publisher's web site.
Notes: Includes bibliographical references (p. 97-99).

Also available in Open Book format via the National Academies Press home page.
Table of contents: title: Introduction; title: Why combinations and collaborations are necessary; title: Scientific challenges in developing investigational combination therapies; title: Overcoming cultural challenges to collaborations; title: Legal issues in collaborations; title: Financial challenges; title: Regulatory issues; title: Codevelopment of therapies for HIV as a model; title: Examples of collaborations relevant to cancer; title: Wrapping up.